Skip to Content
Merck
All Photos(1)

Key Documents

306185

Sigma-Aldrich

Polyethylenimine

80% ethoxylated solution, 37 wt. % in H₂O

Synonym(s):

PEI

Sign Into View Organizational & Contract Pricing


About This Item

CAS Number:
MDL number:
UNSPSC Code:
12162002
NACRES:
NA.23

product name

Polyethylenimine, 80% ethoxylated solution, 37 wt. % in H2O

form

liquid

Quality Level

mol wt

Mw 110,000

concentration

37 wt. % in H2O

pH

12

transition temp

pour point 0 °C

density

1.08 g/mL at 25 °C

Looking for similar products? Visit Product Comparison Guide

Application

Additive to coatings and printing inks, brightener in electroplating, cationic modifier in clays and starches and adhesion/substantivity promoter.

Features and Benefits

Base polymer
Non-yellowing, film forming polyamine. Highly branched, symmetrical polymer. About 80% of the primary and secondary amines are ethoxylated.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Qingzha Deng et al.
Stem cell research & therapy, 11(1), 143-143 (2020-04-05)
Factors such as poor engraftment, retention, and survival of the transplanted stem cells are deemed to limit their therapeutic efficacy for wound regeneration. Hence, it is necessary to explore these issues in order to resolve them. In this study, we

Articles

Gene therapy has become one of the most discussed techniques in biomedical research in recent years.

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

See All

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service